Good Results For Anacetrapib Trial For Those With Coronary Heart Disease
Links shared publicly online about this topic.
- 719total visits
Good Results For Anacetrapib Trial For Those With Coronary Heart Disease
A Phase III trial showed that Merck's investigational CETP inhibitor, Anacetrapib lowered bad cholesterol (LDL) and raised good cholesterol (HDL) considerably in patients with coronary heart disea
View full resource at medicalnewstoday.com
Tags: Heart, Heart Disease, Coronary Artery Disease, Cholesterol, Disease and Condition, Merck & Co., disease
Most Recently Shared on November 18, 2010 at 3:07 pm By:
Good Results For Anacetrapib Trial For Those With Coronary Heart Disease: A Phase III trial showed that Merck's ... http://bit.ly/9xZfM3
Also Shared By:
Advertisement
Thomas Loarie, Jr
@MedHealthNews
Good Results For Anacetrapib Trial For Those With Coronary Heart Disease http://t.co/yp1a9mS via @mnt_heart
1 year ago...